Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Thromboprophylaxis × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6375 Neoplasms 3998 Prostatic Neoplasms 3109 Colorectal Neoplasms 2589 Carcinoma, Non-Small-Cell Lung 2471 Lung Neoplasms 2232 Leukemia, Myeloid, Acute 1726 Pancreatic Neoplasms 1665 Multiple Myeloma 1600 Carcinoma, Hepatocellular 1516 Neoplasm Metastasis 1385 Stomach Neoplasms 1333 Lymphoma 1294 Head and Neck Neoplasms 1255 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1253 Brain Neoplasms 1230 Ovarian Neoplasms 1192 Melanoma 1186 Leukemia 1167 Rectal Neoplasms 1105 Recurrence 1089 Colonic Neoplasms 1048 Glioblastoma 1020 Uterine Cervical Neoplasms 938 Lymphoma, Non-Hodgkin 934 Leukemia, Lymphocytic, Chronic, B-Cell 860 Esophageal Neoplasms 848 Lymphoma, Follicular 815 Lymphoma, Large B-Cell, Diffuse 810 Myelodysplastic Syndromes 797

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡